Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Neven

Showing results (121-130 of 383) with videos related to

Pageof 39
Sort By:
Aging|May 21, 2015
Biological ageing and frailty markers in breast cancer patientsBarbara Brouwers, Bruna Dalmasso, Sigrid Hatse, et al.
Menopause (New York, N.Y.)|October 14, 2011
Gynecologic effects of arzoxifene in postmenopausal women with osteoporosis or low bone massSteven R Goldstein, Harjit Pal Bhattoa, Patrick Neven, et al.
BMC Cancer|October 24, 2018
Age-related microRNAs in older breast cancer patients: biomarker potential and evolution during adjuvant chemotherapyBruna Dalmasso, Sigrid Hatse, Barbara Brouwers, et al.
Breast Cancer Research : BCR|November 11, 2023
AMEERA-4: a randomized, preoperative window-of-opportunity study of amcenestrant versus letrozole in early breast cancerMario Campone, François-Clément Bidard, Patrick Neven, et al.
Cancers|September 9, 2023
Differences in the Tumor Molecular and Microenvironmental Landscape between Early (Non-Metastatic) and De Novo Metastatic Primary Luminal Breast TumorsYentl Lambrechts, Sigrid Hatse, François Richard, et al.
Frontiers in Pharmacology|April 17, 2020
Integrated Data Analysis of Six Clinical Studies Points Toward Model-Informed Precision Dosing of TamoxifenLena Klopp-Schulze, Anna Mueller-Schoell, Patrick Neven, et al.
Maturitas|June 22, 2005
Comparing raloxifene with continuous combined estrogen-progestin therapy in postmenopausal women: Review of Euralox 1Patrick Neven, Deborah Quail, Fernando Marin, et al.
Breast (Edinburgh, Scotland)|August 2, 2016
Arm lymphoedema and upper limb impairments in sentinel node-negative breast cancer patients: A one year follow-up studyAn De Groef, Marijke Van Kampen, Elena Tieto, et al.
Clinical Breast Cancer|October 22, 2011
Immediate Administration of Zoledronic Acid Reduces Aromatase Inhibitor-Associated Bone Loss in Postmenopausal Women With Early Breast Cancer: 12-month analysis of the E-ZO-FAST trialAntonio Llombart, Antonio Frassoldati, Outi Paija, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 2008
Polysomy 17 in breast cancer: clinicopathologic significance and impact on HER-2 testingIsabelle Vanden Bempt, Peter Van Loo, Maria Drijkoningen, et al.
Pageof 39

Showing results (121-130 of 383) with videos related to

Sort By:
Pageof 39
Aging|May 21, 2015
Biological ageing and frailty markers in breast cancer patientsBarbara Brouwers, Bruna Dalmasso, Sigrid Hatse, et al.
Menopause (New York, N.Y.)|October 14, 2011
Gynecologic effects of arzoxifene in postmenopausal women with osteoporosis or low bone massSteven R Goldstein, Harjit Pal Bhattoa, Patrick Neven, et al.
BMC Cancer|October 24, 2018
Age-related microRNAs in older breast cancer patients: biomarker potential and evolution during adjuvant chemotherapyBruna Dalmasso, Sigrid Hatse, Barbara Brouwers, et al.
Breast Cancer Research : BCR|November 11, 2023
AMEERA-4: a randomized, preoperative window-of-opportunity study of amcenestrant versus letrozole in early breast cancerMario Campone, François-Clément Bidard, Patrick Neven, et al.
Cancers|September 9, 2023
Differences in the Tumor Molecular and Microenvironmental Landscape between Early (Non-Metastatic) and De Novo Metastatic Primary Luminal Breast TumorsYentl Lambrechts, Sigrid Hatse, François Richard, et al.
Frontiers in Pharmacology|April 17, 2020
Integrated Data Analysis of Six Clinical Studies Points Toward Model-Informed Precision Dosing of TamoxifenLena Klopp-Schulze, Anna Mueller-Schoell, Patrick Neven, et al.
Maturitas|June 22, 2005
Comparing raloxifene with continuous combined estrogen-progestin therapy in postmenopausal women: Review of Euralox 1Patrick Neven, Deborah Quail, Fernando Marin, et al.
Breast (Edinburgh, Scotland)|August 2, 2016
Arm lymphoedema and upper limb impairments in sentinel node-negative breast cancer patients: A one year follow-up studyAn De Groef, Marijke Van Kampen, Elena Tieto, et al.
Clinical Breast Cancer|October 22, 2011
Immediate Administration of Zoledronic Acid Reduces Aromatase Inhibitor-Associated Bone Loss in Postmenopausal Women With Early Breast Cancer: 12-month analysis of the E-ZO-FAST trialAntonio Llombart, Antonio Frassoldati, Outi Paija, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 2008
Polysomy 17 in breast cancer: clinicopathologic significance and impact on HER-2 testingIsabelle Vanden Bempt, Peter Van Loo, Maria Drijkoningen, et al.
Pageof 39